You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Narcolepsy Therapeutics Market Research: Global Status & Forecast by Geography, Type & Application (2017-2027)

According to 99Strategy, the Global Narcolepsy Therapeutics Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Narcolepsy Therapeutics market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
Addrenex Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals PLC
Graymark Healthcare, Inc.
Arena Pharmaceuticals, Inc.
BIOPROJET
Shire
Ligand Pharmaceuticals, Inc.
Key Product Type
Central nervous system stimulants
Sodium Oxybate
Selective Serotonin Reuptake Inhibitor (SSRI)
Tricyclic Antidepressants
Others
Market by Application
Narcolepsy With Cataplexy
Narcolepsy Without Cataplexy
Secondary Narcolepsy
Main Aspects covered in the Report
Overview of the Narcolepsy Therapeutics market including production, consumption, status & forecast and market growth
2017-2021 historical data and 2022-2027 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development
Table of Content
1 Industrial Chain Overview
1.1 Narcolepsy Therapeutics Industry
1.1.1 Overview
Figure Narcolepsy Therapeutics Picture List
1.1.2 Characteristics of Narcolepsy Therapeutics
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Central nervous system stimulants
1.3.2 Sodium Oxybate
1.3.3 Selective Serotonin Reuptake Inhibitor (SSRI)
1.3.4 Tricyclic Antidepressants
1.3.5 Others
1.4 End-Use List
1.4.1 Demand in Narcolepsy With Cataplexy
1.4.2 Demand in Narcolepsy Without Cataplexy
1.4.3 Demand in Secondary Narcolepsy
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2017-2027
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027
Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
2.1.2 Global Consumption
Figure Global Market Volume and Growth Rate, 2017-2021, in Volume
Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.2 North America
Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.3 South America
Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.4 Europe
Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.2 North America
Figure North America Market Volume and Growth Rate, 2017-2021, in Volume
Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.3 South America
Figure South America Market Volume and Growth Rate, 2017-2021, in Volume
Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.4 Europe
Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume
Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2021
3.2 Manufacturers List
3.2.1 Addrenex Pharmaceuticals, Inc. Overview
Table Addrenex Pharmaceuticals, Inc. Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Narcolepsy Therapeutics Business Operation of Addrenex Pharmaceuticals, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Teva Pharmaceutical Industries Ltd. Overview
Table Teva Pharmaceutical Industries Ltd. Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Narcolepsy Therapeutics Business Operation of Teva Pharmaceutical Industries Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Jazz Pharmaceuticals PLC Overview
Table Jazz Pharmaceuticals PLC Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Narcolepsy Therapeutics Business Operation of Jazz Pharmaceuticals PLC (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Graymark Healthcare, Inc. Overview
Table Graymark Healthcare, Inc. Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Narcolepsy Therapeutics Business Operation of Graymark Healthcare, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Arena Pharmaceuticals, Inc. Overview
Table Arena Pharmaceuticals, Inc. Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Narcolepsy Therapeutics Business Operation of Arena Pharmaceuticals, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 BIOPROJET Overview
Table BIOPROJET Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Narcolepsy Therapeutics Business Operation of BIOPROJET (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Shire Overview
Table Shire Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Narcolepsy Therapeutics Business Operation of Shire (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Ligand Pharmaceuticals, Inc. Overview
Table Ligand Pharmaceuticals, Inc. Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Narcolepsy Therapeutics Business Operation of Ligand Pharmaceuticals, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2017-2021, in Volume
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Volume List by Manufacturers, 2017-2021, in Volume
Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume
Figure Global Production Volume Share by Manufacturers in 2021, in Volume
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume
5.2 Segment Subdivision by Product Type
5.2.1 Market in Central nervous system stimulants
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Central nervous system stimulants, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Central nervous system stimulants, 2017-2021, in Volume
5.2.1.2 Situation & Development
5.2.2 Market in Sodium Oxybate
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Sodium Oxybate, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Sodium Oxybate, 2017-2021, in Volume
5.2.2.2 Situation & Development
5.2.3 Market in Selective Serotonin Reuptake Inhibitor (SSRI)
5.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Selective Serotonin Reuptake Inhibitor (SSRI), 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Selective Serotonin Reuptake Inhibitor (SSRI), 2017-2021, in Volume
5.2.3.2 Situation & Development
5.2.4 Market in Tricyclic Antidepressants
5.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Tricyclic Antidepressants, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Tricyclic Antidepressants, 2017-2021, in Volume
5.2.4.2 Situation & Development
5.2.5 Market in Others
5.2.5.1 Market Size
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in Volume
5.2.5.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume
6.2 Segment Subdivision
6.2.1 Market in Narcolepsy With Cataplexy
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Narcolepsy With Cataplexy, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Narcolepsy With Cataplexy, 2017-2021, in Volume
6.2.1.2 Situation & Development
6.2.2 Market in Narcolepsy Without Cataplexy
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Narcolepsy Without Cataplexy, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Narcolepsy Without Cataplexy, 2017-2021, in Volume
6.2.2.2 Situation & Development
6.2.3 Market in Secondary Narcolepsy
6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Secondary Narcolepsy, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Secondary Narcolepsy, 2017-2021, in Volume
6.2.3.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
Table Global Market Forecast by Region Segment 2022-2027, in Volume
7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2022-2027, in Million USD
Table Global Market Volume by Product Type Segment 2022-2027, in Volume
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
Table Global Market Volume by End-Use Segment 2022-2027, in Volume
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Narcolepsy Therapeutics Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 Research Conclusion